亚临床瓣叶血栓对TAVR后瓣膜血流动力学的影响
ADAPT-TAVR随机试验纳入211例成功行经导管主动脉瓣置换术(TAVR)的患者,评估低衰减瓣叶增厚(HALT)对瓣膜血流动力学的影响。6个月时HALT发生率为14.2%,HALT组与非HALT组的主动脉瓣平均压差无显著差异(14.0±4.8 vs 13.7±5.5 mm Hg,p=0.74)。HALT并非血流动力学结构性瓣膜退化(SVD)的预测因素,SVD的独立预测因素包括高龄、使用≤23 mm瓣膜及术后平均压差较高。
要点
- TAVR术后6个月HALT发生率为14.2%,未显著影响主动脉瓣平均压差。
- HALT不是6个月时血流动力学SVD的预测因素。
- SVD的独立预测因素包括高龄、瓣膜尺寸≤23 mm及术后平均压差。
核心结论
- 在成功行TAVR的患者中,HALT的存在不影响主动脉瓣血流动力学状态。
- HALT不是6个月时血流动力学SVD的预测因素,但需更长期随访评估其对瓣膜耐久性的影响。
研究设计与样本
- ADAPT-TAVR试验为多中心随机试验,比较艾多沙班与双联抗血小板治疗在成功行TAVR患者中的效果。
- HALT通过6个月时四维CT评估,并在基线、TAVR后即刻及6个月后行连续超声心动图检查。
- SVD定义为满足以下至少一项:平均跨瓣压差≥20 mm Hg、平均压差较基线变化≥10 mm Hg、或新发/加重的瓣内主动脉瓣反流至少≥1级导致中度及以上反流。
主要发现
- 6个月时HALT见于211例患者中的30例(14.2%)。
- HALT组与非HALT组6个月时主动脉瓣平均压差分别为14.0±4.8 mm Hg与13.7±5.5 mm Hg,差异无统计学意义(p=0.74)。
- 6个月随访超声心动图报告SVD见于206例患者中的30例(14.6%)。
- 血流动力学SVD的独立预测因素包括高龄(OR: 1.138; 95% CI: 1.019 to 1.293; p=0.033)、使用主动脉瓣尺寸≤23 mm(OR: 6.254; 95% CI: 2.230 to 20.569; p=0.001)及TAVR后平均压差(OR: 1.233; 95% CI: 1.123 to 1.371; p<0.001)。
- HALT未被识别为SVD的预测因素。
关键数值与推荐
- SVD诊断标准:平均跨瓣压差≥20 mm Hg,或平均压差较基线变化≥10 mm Hg,或新发/加重的瓣内主动脉瓣反流至少≥1级导致中度及以上反流。
临床怎么用
- 对于TAVR术后6个月内的患者,HALT的存在不显著影响瓣膜平均压差,不应仅凭HALT判断血流动力学恶化。
- 高龄、使用≤23 mm瓣膜及术后平均压差较高的患者应关注SVD风险。
局限性
- 研究仅评估6个月时的HALT和血流动力学SVD,需更长期随访评估HALT对瓣膜耐久性的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The effect of subclinical leaflet thrombosis, characterised by hypoattenuated leaflet thickening (HALT), on the valve haemodynamic function and durability of the bioprosthetic valve, is not yet determined. We determined the impact of HALT on valve haemodynamics after transcatheter aortic valve replacement (TAVR) and the predictors of haemodynamic structural valve deterioration (SVD). METHODS: The Anticoagulation vs Dual Antiplatelet Therapy for Prevention of Leaflet Thrombosis and Cerebral Embolization after Transcatheter Aortic Valve Replacement(ADAPT-TAVR) trial is a multicenter, randomised trial that compared edoxaban and dual antiplatelet therapy in patients who had undergone successful TAVR. The presence of HALT was evaluated by four-dimensional CT at 6 months and serial echocardiography performed at baseline, immediately post-TAVR and after 6 months. SVD was defined as at least one of the following: (1) mean transprosthetic gradient ≥20 mm Hg, (2) change in the mean gradient ≥10 mm Hg from baseline, or (3) new or increase in intraprosthetic aortic regurgitation of at least ≥1 grade, resulting in moderate or greater regurgitation. RESULTS: At 6 months, HALT was found in 30 of 211 (14.2%) patients. The presence of HALT did not significantly affect aortic valve mean gradients (with vs without HALT; 14.0±4.8 mm Hg vs 13.7±5.5 mm Hg; p=0.74) at 6 months. SVD was reported in 30 of 206 patients (14.6%) at 6-month follow-up echocardiography. Older age (OR: 1.138; 95% CI: 1.019 to 1.293; p=0.033), use of aortic valve size ≤23 mm (OR: 6.254; 95% CI: 2.230 to 20.569; p=0.001) and mean post-TAVR pressure gradient (OR: 1.233; 95% CI: 1.123 to 1.371; p<0.001) were independent predictors of haemodynamic SVD; however, the presence of HALT was not identified as a predictor of SVD. CONCLUSIONS: In patients who had undergone successful TAVR, aortic valve haemodynamic status was not influenced by the presence of HALT. Although HALT was not a predictor of haemodynamic SVD at 6 months, it warrants further longer-term follow-up to evaluate the effect on long-term valve durability. TRIAL REGISTRATION NUMBER: NCT03284827 (https://www. CLINICALTRIALS: gov).
引用
- Jang MH, Ahn JM, Kang DY, et al. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement. Heart. 2023. PMID: 37586823. doi:10.1136/heartjnl-2023-322946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。